Internal Medicine Department, Nephrology Division, Hospital General Juan Cardona c/ Pardo Bazán s/n, 15406 Ferrol, Spain.
University of Santiago de Compostela Medical School, Santiago de Compostela, Acoruna, Spain.
Curr Diabetes Rev. 2023;19(1):e280322202705. doi: 10.2174/1573399818666220328145046.
Histological manifestations of diabetic kidney disease (DKD) include mesangiolysis, mesangial matrix expansion, mesangial cell proliferation, thickening of the glomerular basement membrane, podocyte loss, foot process effacement, and hyalinosis of the glomerular arterioles, interstitial fibrosis, and tubular atrophy. Glomerulomegaly is a typical finding. Histological features of DKD may occur in the absence of clinical manifestations, having been documented in patients with normal urinary albumin excretion and normal glomerular filtration rate. Furthermore, the histological picture progresses over time, while clinical data may remain normal. Conversely, histological lesions of DKD improve with metabolic normalization following effective pancreas transplantation. Insulin resistance has been associated with the clinical manifestations of DKD (nephromegaly, glomerular hyperfiltration, albuminuria, and kidney failure). Likewise, insulin resistance may underlie the histological manifestations of DKD. Morphological changes of DKD are absent in newly diagnosed type 1 diabetes patients (with no insulin resistance) but appear afterward when insulin resistance develops. In contrast, structural lesions of DKD are typically present before the clinical diagnosis of type 2 diabetes. Several heterogeneous conditions that share the occurrence of insulin resistance, such as aging, obesity, acromegaly, lipodystrophy, cystic fibrosis, insulin receptor dysfunction, and Alström syndrome, also share both clinical and structural manifestations of kidney disease, including glomerulomegaly and other features of DKD, focal segmental glomerulosclerosis, and C3 glomerulopathy, which might be ascribed to the reduction in the synthesis of factor H binding sites (such as heparan sulfate) that leads to uncontrolled complement activation. Alström syndrome patients show systemic interstitial fibrosis markedly similar to that present in diabetes.
糖尿病肾病(DKD)的组织学表现包括系膜溶解、系膜基质扩张、系膜细胞增殖、肾小球基底膜增厚、足细胞丢失、足突融合和肾小球小动脉玻璃样变、间质纤维化和肾小管萎缩。肾小球肿大是一种典型的表现。DKD 的组织学特征可能在没有临床表现的情况下发生,在尿白蛋白排泄正常和肾小球滤过率正常的患者中已有记录。此外,组织学图像随时间进展,而临床数据可能保持正常。相反,在胰腺移植有效后代谢正常化,DKD 的组织学病变会得到改善。胰岛素抵抗与 DKD 的临床表现(肾肿大、肾小球高滤过、白蛋白尿和肾衰竭)有关。同样,胰岛素抵抗可能是 DKD 组织学表现的基础。新诊断的 1 型糖尿病患者(无胰岛素抵抗)没有 DKD 的形态变化,但当胰岛素抵抗发生后才会出现。相比之下,DKD 的结构病变在 2 型糖尿病的临床诊断之前通常已经存在。一些具有胰岛素抵抗共同发生的异质性疾病,如衰老、肥胖、肢端肥大症、脂肪营养不良、囊性纤维化、胰岛素受体功能障碍和 Alström 综合征,也具有共同的临床和结构表现的肾脏疾病,包括肾小球肿大和其他 DKD 的特征、局灶节段性肾小球硬化和 C3 肾小球病,这可能归因于因子 H 结合位点(如肝素硫酸盐)合成减少,导致不受控制的补体激活。Alström 综合征患者表现出与糖尿病中相似的系统性间质纤维化。